Simon Robinson

2019

In 2019, Simon Robinson earned a total compensation of $1M as Senior Vice President, Research and Pharma Development at Lantheus Holdings.

Compensation breakdown

Non-Equity Incentive Plan$149,001
Salary$337,588
Stock Awards$511,032
Other$12,600
Total$1,010,221

Robinson received $511K in stock awards, accounting for 51% of the total pay in 2019.

Robinson also received $149K in non-equity incentive plan, $337.6K in salary and $12.6K in other compensation.

Rankings

In 2019, Simon Robinson's compensation ranked 9,216th out of 13,971 executives tracked by ExecPay. In other words, Robinson earned more than 34.0% of executives.

ClassificationRankingPercentile
All
9,216
out of 13,971
34th
Division
Manufacturing
3,690
out of 5,695
35th
Major group
Chemicals And Allied Products
1,401
out of 2,194
36th
Industry group
Drugs
1,194
out of 1,880
37th
Industry
In Vitro and In Vivo Diagnostic Substances
36
out of 77
53rd
Source: SEC filing on March 12, 2020.

Robinson's colleagues

We found five more compensation records of executives who worked with Simon Robinson at Lantheus Holdings in 2019.

2019

Mary Heino

Lantheus Holdings

Chief Executive Officer

2019

Robert Marshall

Lantheus Holdings

Chief Financial Officer

2019

Michael Duffy

Lantheus Holdings

General Counsel

2019

Cesare Orlandi

Lantheus Holdings

Chief Medical Officer

2019

John Bolla

Lantheus Holdings

Chief Operations Officer

News

You may also like